or
forgot password
  • cancer clinical trials in chicago, IL

  • Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Rush University Medical Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology and Oncology Associates
    Leukemia
    Phase II Study in Patients With Operable Breast Cancer
    John H. Stroger, Jr. Hospital of Cook County
    Chicago, Illinois 60612-9985
    Breast Cancer
    Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
    Northwestern University
    Chicago, Illinois 60611
    Head and Neck Neoplasms
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Hematology and Oncology Associates

    Trial Locations
    Hematology and Oncology Associates
    Northwestern University
    John H Stroger Jr Hospital of Cook County
    University of Illinois
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
    1200.22.18 Boehringer Ingelheim Investigational Site
    Chicago, Illinois
    Carcinoma, Non-Small-Cell Lung
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
    University of Chicago
    Chicago, Illinois 60637
    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML)
    Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Liver Cancer
    Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
    Northwestern University
    Chicago, Illinois 60611
    Multiple Myeloma
    Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
    University of Chicago Medical Center
    Chicago, Illinois 60637
    Breast Cancer, Cancer of the Breast, Breast Neoplasm
    Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
    Northwestern University
    Chicago, Illinois 60611
    Ovarian Cancer, Renal Cancer, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Solid Tumors, Multiple Myeloma, Lymphoma
    Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Liver Cancer, Metastatic Cancer
    High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center
    Lung Cancer, Radiation Toxicity
    Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer
    University of Chicago Medical Center
    Chicago, Illinois 60637
    Pancreatic Cancer
    Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Borderline Ovarian Surface Epithelial-stromal Tumor, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor
    S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology and Oncology Associates
    Leukemia
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    University of Illinois Cancer Center
    Lymphoma
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Children's Memorial Hospital - Chicago
    University of Illinois Cancer Center
    Leukemia
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    Northwestern University
    University of Chicago Comprehensive Cancer Center
    University of Illinois
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    John H. Stroger, Jr. Hospital of Cook County
    Chicago, Illinois 60612-9985
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Children's Memorial Hospital - Chicago
    University of Illinois Cancer Center
    Neuroblastoma
    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center

    Trial Locations
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center
    Mount Sinai Hospital Medical Center
    Prostate Cancer
    Safety Study of TAK-700 in Subjects With Prostate Cancer.
    Northwestern University Medical Center

    Trial Locations
    Northwestern University Medical Center
    University of Chicago
    University of Chicago Comprehensive Cancer Center
    University of Chicago Pharmacy
    Prostatic Neoplasms
    Efficacy and Safety of OncoGelâ„¢ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    University of Chicago Medical Center
    Esophageal Cancer, Adenocarcinoma of the Esophagus, Squamous Cell Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Hematology and Oncology Associates

    Trial Locations
    Hematology and Oncology Associates
    Northwestern University
    Mount Sinai Hospital Medical Center
    John H Stroger Jr Hospital of Cook County
    Resurrection Healthcare
    University of Illinois
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary